Seventh Framework Programme and European Commission logos

Advancing the development of life-saving drugs for cardiovascular diseases

CarTarDis cardiovascular target validation results published in Circulation

We are proud to announce that the results of the validation of the selected CarTarDis targets have been and will be disseminated in scientific manuscripts and posters. The abstracts of the most recent posters, presented at the American Heart Association conference in Anaheim, CA in November 2017, have been published in Circulation, , ,

In Situ Multimodal Molecular Imaging and Staining Technologies Supporting Target Validation in Cardiovascular Disease   http://circ.ahajournals.org/content/136/Suppl_1/A17220

AHA2017_CarTarDis_Technology_poster

Adenosine Deaminase 2 Inhibits Adenosine-Driven Neutrophil Activation in Atherosclerosis http://circ.ahajournals.org/content/136/Suppl_1/A16362

AHA2017_ADA2 poster

Lipid Phosphate Phosphatase 3 and Lysophosphatidic Acid Receptors Expression in Human Atherosclerotic Plaques: Co-Localization of Relevant Lipid http://circ.ahajournals.org/content/136/Suppl_1/A20282

AHA2017_PPAB2B validation poster

Inflammatory Cytokine Oncostatin M Induces Endothelial Activation in vitro and in APOE*3Leiden.CETP Mice http://circ.ahajournals.org/content/136/Suppl_1/A19930

AHA2017_ Oncostatin M_poster